MiMedx

Back to All Transactions

MiMedx
For more information regarding this transaction contact:
  • Mike Townley Investment Banking 213.536.0241

MiMedx Group, Inc. 

Lake Street is pleased to announce it served as co-managing underwriter for MiMedx Group, Inc. (NASDAQ: MDXG), a manufacturer and marketer of biomaterial-based products, in its public offering of 5,750,000 shares of common stock at a price of $6.80 per share.  Gross proceeds totaled $39M.

About MiMedx Group, Inc.

Headquartered in Marietta, Georgia, the Company operates as an integrated developer, manufacturer, and marketer of patent-protected regenerative biomaterials and bioimplants processed from human amniotic membrane.  The Company sells its products through a combination of a direct sales force, independent stocking distributors, and representatives in the United Stated, as well as through independent distributors internationally.

Contact

Mike Townley
Head of Investment Banking

612.326.1313

Email Mike
 

Dave McDonald
Head of Life Science Investment Banking

612.326.1268

Email Dave

 

Tim Klein

Investment Banking

612.260.6173

Email Tim

 

Rob Martin

Investment Banking

612.260.5850

Email Rob

 

Steve Rickman

Investment Banking

612.326.1985

Email Steve